9.445
전일 마감가:
$9.03
열려 있는:
$9.01
하루 거래량:
77,361
Relative Volume:
0.46
시가총액:
$9.42M
수익:
$12.99M
순이익/손실:
$-23.72M
주가수익비율:
-0.0971
EPS:
-97.2514
순현금흐름:
$-23.28M
1주 성능:
-2.23%
1개월 성능:
-52.30%
6개월 성능:
-82.68%
1년 성능:
-99.42%
Aptevo Therapeutics Inc Stock (APVO) Company Profile
명칭
Aptevo Therapeutics Inc
전화
206-838-0500
주소
2401 4TH AVE., SEATTLE, WA
APVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
APVO
Aptevo Therapeutics Inc
|
9.445 | 9.01M | 12.99M | -23.72M | -23.28M | -97.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2018-11-05 | 개시 | Ladenburg Thalmann | Buy |
| 2017-10-05 | 재개 | Piper Jaffray | Overweight |
Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스
Aptevo Therapeutics (NASDAQ: APVO) seeks OK for $60M SEPA share sales - Stock Titan
Income Plays: Does Eastman Kodak Company align with a passive investing strategy - baoquankhu1.vn
Market Overview: How sensitive is HUHUTECH International Group Inc to inflationJuly 2025 Movers & Verified Momentum Stock Watchlist - baoquankhu1.vn
Market Fear: Is Aptevo Therapeutics Inc stock trending bullishWeekly Trading Summary & Consistent Growth Stock Picks - baoquankhu1.vn
HOKA Size Guide: What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - Улправда
Aptevo Therapeutics Secures $60 Million Equity Financing Facility - The Globe and Mail
Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aptevo Therapeutics shares jump after $60 million equity facility secured - MSN
Aptevo Therapeutics stock jumps after securing $60 million equity line By Investing.com - Investing.com South Africa
Aptevo Therapeutics stock jumps after securing $60 million equity line - Investing.com
Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality - The Globe and Mail
Aptevo secures $60 million equity line of credit to fund operations - Investing.com Nigeria
Aptevo Therapeutics (APVO) Secures $60 Million Equity Line - GuruFocus
Aptevo Therapeutics enters equity purchase agreement with YA II PN, Ltd - marketscreener.com
Aptevo Therapeutics Signs Standby Equity Purchase Agreement With Yorkville - TradingView — Track All Markets
Biotech lines up $60M to keep next-wave cancer drugs moving to 2029 - Stock Titan
What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - Улправда
Will Aptevo Therapeutics Inc. (AP81) stock maintain strong growthWeekly Stock Recap & Community Supported Trade Ideas - Улправда
Will Aptevo Therapeutics Inc. stock deliver shareholder valueEarnings Risk Report & Low Risk High Reward Trade Ideas - Улправда
Will Aptevo Therapeutics Inc. stock continue upward momentum2025 Top Decliners & Fast Momentum Entry Tips - Улправда
Is Aptevo Therapeutics Inc. stock a smart buy before Fed meetingPortfolio Performance Summary & Free Verified High Yield Trade Plans - Улправда
Quarterly Trades: What consensus target says about Aptevo Therapeutics Inc. (AP81) stockCEO Change & Risk Controlled Daily Trade Plans - Улправда
Is Aptevo Therapeutics Inc. stock a buy for dividend growthRisk Management & Technical Confirmation Trade Alerts - Улправда
Quarterly Recap: Will Aptevo Therapeutics Inc stock continue upward momentumAnalyst Downgrade & Growth Oriented Trade Recommendations - Bộ Nội Vụ
Aptevo Therapeutics announces 1-for-18 reverse stock split - MSN
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis By Investing.com - Investing.com Australia
Aptevo Therapeutics enacts 1-for-18 reverse stock split, shares to trade on split-adjusted basis - Investing.com Australia
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split - TipRanks
Aptevo Therapeutics To Implement 1-for-18 Reverse Stock Split - Nasdaq
Aptevo Therapeutics Inc. (APVO) Stock: Plummets 36% Ahead of 1-for-18 Reverse Split - parameter.io
Aptevo Therapeutics Stock Slumps To All-Time Low On Reverse Split Approval - Asianet Newsable
Why Aptevo Therapeutics Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Benzinga
Aptevo Therapeutics (APVO) Announces 1-for-18 Reverse Stock Spli - GuruFocus
Aptevo Therapeutics stock slumps to all-time low on reverse split approval - MSN
What's Going On With Aptevo Therapeutics Stock Today?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga
Aptevo Therapeutics to implement 1-for-18 reverse stock split By Investing.com - Investing.com Nigeria
US Stocks Mixed; Biohaven Shares Fall - Benzinga
Aptevo Therapeutics to implement 1-for-18 reverse stock split - Investing.com
Aptevo Therapeutics stock tumbles after announcing 1-for-18 reverse split - Investing.com India
Aptevo Therapeutics Inc (APVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):